NCT04240223 - A Study to Investigate the Use of Delayed Release Tablets for Colonic Delivery of Brilacidin in Healthy Volunteers | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 6, 2020

Primary Completion Date

February 12, 2020

Study Completion Date

February 12, 2020

Conditions

Healthy Volunteers

Interventions

DRUG

Brilacidin

DRUG

Placebo

RADIATION

4Mq 99mTc-DTPA

4Mq technetium-99m (99mTc), complexed with diethylenetriaminepentaacetic acid (DTPA) which prevents absorption of the radioisotope from the gastrointestinal tract

Trial Locations (1)

G4 0SF

BDD Pharma Ltd, Glasgow